Neutral
CASI Pharmaceuticals (CASIF) files Nasdaq Form 25 to delist Ordinary Shares
CASI Pharmaceuticals, Inc. (CASIF) has filed a Form 25 with Nasdaq to remove its Ordinary Shares from listing and/or registration under Section 12(b)....